-
New Forum Software Installed (Still a few issues but reopening the forum) More details.
guanfacine
-
Hyperadrenergic Postural Tachycardia Syndrome: Clinical Biomarkers and Response to Guanfacine, 2024, Okamoto et al.
Abstract BACKGROUND: A subset of patients with postural tachycardia syndrome (POTS) are thought to have a primary hyperadrenergic cause. We assessed clinical biomarkers to identify those that would benefit from sympatholytic therapy. METHODS: We measured sympathetic function (supine muscle...- InitialConditions
- Thread
- guanfacine pots
- Replies: 2
- Forum: 'Conditions related to ME/CFS' news and research